ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

A class action securities lawsuit has been filed against ADMA Biologics, Inc. for investors who purchased securities between August 9, 2024 and March 25, 2026. The lawsuit alleges the company and its executives failed to disclose material information, including undisclosed related party transactions, channel stuffing to inflate revenue, and inadequate internal controls. The case is pending in the U.S. District Court for the District of New Jersey, with an August 10, 2026 deadline for investors to request lead plaintiff status.